Clinical Trials Browser

Phase 3 × motesanib diphosphate × Clear all

NCT02629848 2015-12-14

Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00460317 2015-09-07

MONET1-MOtesanib NSCLC Efficacy and Tolerability Study

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasms